Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 26

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 26
---
 a company complies.

If, however, the Company
does not achieve compliance with the Minimum Bid Price Requirement by August 6, 2025, the Company may be eligible for additional time
to comply. In order to be eligible for such additional time, the Company will be required to meet the continued listing requirement for
market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the
Minimum Bid Price Requirement, and must notify Nasdaq in writing of its intention to cure the deficiency during the second compliance
period. Accordingly, we are hereby asking our stockholders to approve a reverse split to, among other things, give us the option to seek
to regain compliance with the Minimum Bid Price Requirement.

| 16 |

The Board of Directors believes that
the failure of stockholders to approve the Reverse Stock Split Proposal could prevent us from maintaining compliance with the Minimum
Bid Price Requirement and could inhibit our ability to conduct capital raising activities, among other things. If Nasdaq delists the
Common Stock, then the Common Stock would likely become traded on an over-the-counter market such as those maintained by OTC Markets
Group Inc., which do not have the substantial corporate governance or quantitative listing requirements for continued trading that Nasdaq
has. In that event, interest in the Common Stock may decline, and certain institutions may not have the ability to trade
in the Common Stock, all of which could have a material adverse effect on the liquidity or trading volume of the Common Stock. If the
Common Stock becomes significantly less liquid due to delisting from Nasdaq, our stockholders may not have the ability to liquidate their
investments in the Common Stock as and when desired, and we believe our ability to maintain analyst coverage, attract investor interest, and access capital may become significantly
diminished as a result.

If the stockholders approve the Reverse
Stock Split Proposal and the Board decides to implement the Reverse Stock Split, we will file a certificate of amendment to amend
the existing provision of our Certificate of Incorporation to effect the Reverse Stock Split. The text of the form of proposed amendment
is set forth in the certificate of amendment to the Certificate of Incorporation, which is attached to this Proxy Statement as
.

The Reverse Stock Split will be effected
simultaneously for all issued and outstanding shares of Common Stock, and the Reverse Stock Split Ratio will be the same for all
issued and outstanding shares of Common Stock. The Reverse Stock Split will affect all of our stock